- Home
- LE vs BIOA Comparison
LE vs BIOA Comparison
Compare LE & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LE | BIOA |
|---|---|---|
| Founded | 1963 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.2M | 443.9M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | LE | BIOA |
|---|---|---|
| Price | $18.60 | $20.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $32.50 | ★ $33.33 |
| AVG Volume (30 Days) | 343.9K | ★ 945.6K |
| Earning Date | 03-19-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $1,314,437,000.00 | $5,917,000.00 |
| Revenue This Year | $1.55 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $47.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.65 | $2.88 |
| 52 Week High | $20.04 | $24.00 |
Technical Indicators
Market Signals| Indicator | LE | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 62.33 | 61.75 |
| Support Level | $16.61 | $19.22 |
| Resistance Level | $18.30 | $21.50 |
| Average True Range (ATR) | 1.23 | 1.35 |
| MACD | 0.12 | -0.18 |
| Stochastic Oscillator | 78.38 | 66.52 |
Price Performance
Historical ComparisonAbout LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.